Gene One Life Science postpones paid-in date for KRW 15 billion third-party share sale to Oct. 20
PUBT · 3d ago
Share
Listen to the news
- Gene One Life Science issued a correction to its Aug. 4 filing on a KRW 15 billion third-party allotment capital increase.
- Payment date moved to Oct. 20, 2026 from Sept. 30, 2026.
- New share delivery date shifted to Nov. 4, 2026 from Oct. 16, 2026; listing date also reset to Nov. 4.
- CEO line revised to Kim Kyung-jin from Kim Kyung-jin, Han Woo-geun.
- Deal terms unchanged: 6,224,066 common shares at KRW 2,410 each to Revolt Investment Association, raising KRW 15 billion.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gene One Life Science Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260930000698), on September 30, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending